Showing results (1-10 of 65) with videos related to
Sort By:
Pageof 7
Urologie (Heidelberg, Germany)|November 26, 2024
[Non-clear cell renal cell carcinoma]Marit Ahrens, Lothar BergmannDeutsche Medizinische Wochenschrift (1946)|June 4, 2020
[What is new in the diagnosis and therapy of renal cell carcinoma?]Marit Ahrens, Arndt Hartmann, Lothar BergmannExpert Review of Anticancer Therapy|July 22, 2021
Pathology and systemic therapy of non-clear cell renal cell carcinoma: an overviewLothar Bergmann, Sarah Weber, Arndt Hartmann, et al.Oncology Research and Treatment|February 26, 2019
Non-Clear Cell Renal Cell Carcinoma - Pathology and Treatment OptionsMarit Ahrens, Sebastian Scheich, Arndt Hartmann, et al.Onkologie|February 19, 2010
[Sunitinib--from paradigm shift to standard treatment of metastatic renal cell carcinoma]Lothar BergmannDeutsche Medizinische Wochenschrift (1946)|April 1, 2016
[Systemic therapy of metastatic renal cell carcinoma]Luise Maute, Lothar BergmannOnkologie|February 19, 2010
[Outlook: Future therapy of renal cell carcinoma]Lothar Bergmann, Kurt MillerTumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 22, 2010
Downregulation of STAT3 signaling induces apoptosis but also promotes anti-apoptotic gene expression in human pancreatic cancer cell linesWolfgang Glienke, Eva Hausmann, Lothar BergmannExpert Review of Anticancer Therapy|December 10, 2013
Temsirolimus for advanced renal cell carcinomaLothar Bergmann, Luise Maute, Michael GuschmannTumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 16, 2011
The dual PI3K/mTOR inhibitor NVP-BGT226 induces cell cycle arrest and regulates Survivin gene expression in human pancreatic cancer cell linesWolfgang Glienke, Luise Maute, Johannes Wicht, et al.Pageof 7